Immunotherapy, which leverages the body's immune system to fight cancer, has shown remarkable success in some cancers but not in others. For example, melanoma and certain types of lung cancer respond well to immune checkpoint inhibitors. However, other cancers may not have the necessary markers that make them susceptible to immunotherapy. Ongoing research aims to expand the range of cancers that can be effectively treated with immunotherapy.
